Hansa Biopharma Report First Quarter 2026 Financial Results
· PDUFA target date set for December 19 by the FDA
· Runway significantly extended
Lund, Sweden, 23 April 2026. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced its interim report January-March 2026.
